Abiopharma

Star Therapeutics to Present Complete Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease at ISTH 2026 Congress

Superior Plus Announces Timing of 2026 Second Quarter Results Conference Call and Webcast

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress

Morgan Stanley Wealth Management Expands Access to Private Markets and Alternatives with PMAX - Balanced and PMAX - Growth Funds

Gildan Recognized as One of Canada’s Best 50 Corporate Citizens by Corporate Knights and Among TIME’s World’s Most Sustainable Companies

Visa面向全球推出Visa Destinations服务，重新定义其在旅行领域的角色

HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026

Visa推出全球旅遊平台「Visa Destinations」，重新定義其在該產業中的作用

Director/PDMR Shareholding

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice